Shimadzu’s Nexera XS inert is designed to prevent both adsorption of target molecules to metal surfaces and mobile-phase corrosion.
Shimadzu's Nexera XS Inert
Shimadzu’s Nexera XS inert is a bioinert and biocompatible ultra-high performance liquid chromatography that is designed to prevent the adsorption of target molecules to metal surfaces and mobile-phase corrosion caused by high salt content and extreme pH conditions.
The system utilizes a metalfree sample flow path, which prevents unwanted interaction with biopolymers that are prone to adsorption onto exposed metal sites, resulting in reduced sample loss and excellent peak shape in data results. Additionally, all wetted surfaces of the system use corrosionresistant materials, which are designed to promote stability against mobile-phase solvents that contain high concentrations of salts or acids. This makes it well-suited for analyzing biopharmaceutical molecules, such as antibodies, peptides, and nucleic acid drugs.
The system uses a stainless-steel-casing-reinforced polyether ether ketone tubing to promote mechanical and chemical resistance. It is designed for a pressure tolerance of >100 MPa while maintaining a bioinert flow path. An optional pHM-40 offers realtime measurement of the mobile-phase pH during an experiment.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.